ECCER PANTOPRAZOLE 40MG 28TABS

Description

Pantoprazole is indicated for the healing and prevention of esophageal-gastro-duodenal peptic acid lesions and for the relief of gastrointestinal symptoms associated with acid-peptic disease in those cases in which a sustained control and reduction of gastric secretion of hydrochloric acid is required:

Peptic acid disease manifested as: duodenal ulcer, gastric ulcer, * peptic ulcer associated with Helicobacter pylori infection (* patients with acid peptic lesions associated with Helicobacter pylori infection require additional treatment combined with specific antibiotics for its eradication ), refractory peptic ulcer Helicobacter pylori (-) and other lesions refractory to previous treatment with H2 antagonists. Control of Zollinger-Ellison syndrome, gastroesophageal reflux disease with reflux esophagitis (Savary-Miller grades I, II, III, and IV GERD), mild to moderate esophagitis (Vandenplas grades Ic / II) in children 6 to 12 years; Gastroesophageal reflux esophagitis with manifestations and / or extraesophageal lesions associated with reflux (ie dysphonia, asthma, laryngitis, chronic sinusitis, etc.), mild esophagitis with associated symptoms (eg heartburn, acid regurgitation, odynophagia, etc.), maintenance therapy long-term for the prevention of relapses of gastroesophageal reflux, non-erosive gastroesophageal reflux disease (NERD), treatment of heartburn, dyspepsia and other functional digestive disorders associated with acid peptic disease, acute and chronic gastritis and / or duodenitis, erosive gastritis , treatment and prevention of drug gastritis secondary to chronic consumption of non-steroidal anti-inflammatory drugs (NSAIDs). Preoperative prevention of acid aspiration pneumonia (Mendelson syndrome). As a diagnostic therapeutic test to rule out the origin of non-cardiovascular chest pain.